Addressing this, Dr Naseemuddin expresses, Weight regain is common after discontinuing GLP-1 therapy, but it is not inevitable
Ongoing treatment: 0.5 mg once per week starting on week five
Shared Decision-Making in Oncology The ultimate goals in shared decision-making are a comprehensive, transparent discussion of risks and benefits of each treatment option, including an individualized approach that balances the metabolic, weight loss, and oncologic priorities
The PlexusDx Weight Management Protocols are all-inclusive async provider consultation, prescription, compounded medication, and shipping in one monthly price, with no membership fee: Microdose GLP-1 Protocol $129/mo flat
Food and Drug Administration (FDA) has recently updated its regulations regarding compounding GLP-1 medications , particularly tirzepatide and semaglutide